Renal Pelvis and Ureter Carcinoma — Trials

Renal Pelvis and Ureter Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 27
Ph III recruiting: 6
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 101–105 of 105 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01138124	Gabapentin and Risk of Pancreatic Cancer and Renal Cancer (GPRD)	completed	—	54,202	GlaxoSmithKlineINDUSTRY	0	May 30, 2017	clinicaltrials
NCT02923557	Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Nephroureterectomy for Primary Upper Tract Urothelial Carcinoma Patients	unknown	Phase 2	200	Peking University First HospitalOTHER	1	Nov 17, 2016	clinicaltrials